SPH Notice - Forsyth Barr Group Limited (FBGL)
1
Disclosure of beginning to have substantial holding
Section 276, Financial Markets Conduct Act 2013
To: NZX Limited
and
To: Sanford Limited
Date this disclosure made: 4 June 2026
Date on which substantial holding began: 3 June 2026
Substantial product holder(s) giving
disclosure:
Forsyth Barr Group Limited (FBGL)
and
Forsyth Barr Investment Management Limited
(FBIM), a wholly owned subsidiary of FBGL
and
Forsyth Barr Limited (FBL), a wholly owned
subsidiary of FBGL
Summary of substantial holding
Class of quoted voting products: Sanford Limited Ordinary Shares
Summary for FBIM
For this disclosure,—
(a) total number held in class: 11,585,317
(b) total in class: 93,506,137
(c) total percentage held in class:
12.39%
Details of relevant interests
Details for FBGL
Nature of relevant interest(s):
On 3 June 2026, FBGL entered into a block trade
agreement (Agreement) with Ngāi Tahu
Investments Limited (NTIL) under which NTIL
appointed FBGL to arrange, manage and
underwrite the disposal of 8,969,621 ordinary
shares in Sanford Limited (Sale Shares),
currently held by NTIL, for a sale price to be
determined under the procedures set out in the
Agreement and in any event at least NZ$7.15
per share. As underwriter, FBGL acquired a
relevant interest in the Sale Shares.
A copy of the Agreement, which comprises 18
pages, is attached to this notice.
Settlement of the sale of the Sale Shares is
expected to occur on 9 June 2026.
2
For that relevant interest,—
(a) number held in class: 8,969,621
(b) percentage held in class: 9.59%
(c) current registered holder(s): NTIL
(d) registered holder(s) once transfers are
registered:
Not applicable
Details for FBIM / FBL
Nature of relevant interest(s):
The relevant interest arises under various
investment management agreements to which
FBIM and/or FBL are a party in their capacity as
providers of discretionary investment
management services (DIMS) and from FBIM
being the manager of managed investment
schemes. The relevant interest arises only from
the powers of investment contained in the
relevant agreement documents, including the
power to control the exercise of the right to
vote attached to the shares and to control the
disposal of the shares.
Pursuant to regulation 142, the relevant
agreement documents need not be attached
under regulation 139.
For that relevant interest,—
(a) number held in class: 2,615,696
(b) percentage held in class: 2.90%
(c) current registered holder(s): Forsyth Barr Custodians Limited (FBCL)
(2,396,700)/ Adminis Custodial Nominees
Limited (Adminis) (218,996)
(d) registered holder(s) once transfers are
registered:
Not applicable
For a derivative relevant interest, also—
(a) type of derivative: Not applicable
(b) details of derivative: Not applicable
(c) parties to the derivative: Not applicable
(d) if the substantial product holder is not a
party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
3
Details of transactions and events giving rise to substantial holding
Details of the transactions or other events requiring disclosure in the period 4 February 2026 to
3 June 2026.
Nature of event Consideration Number of
financial
products
Registered
holder(s) prior to
transfer
Registered holder(s)
once transfers were
registered
On-market sales $1,082,727 140,881 FBCL Unknown
On-market
purchases
$532,382 72,411 Unknown FBCL 35,930 /
Adminis 36,481
Off-market transfers
out of DIMS
Nil 20,281 FBCL Unknown
Off-market transfers
into DIMS
Nil
35,296
Unknown FBCL
Block Trade
Underwriter
Agreement
Nil 8,969,621 NTIL
n/a
Additional information
Address(es) of substantial product holder(s): Forsyth Barr House, The Octagon, Dunedin
Contact details: Amanda Koo
T: 09 368 0118
E: compliance@forsythbarr.co.nz
Name of any other person believed to have
given, or believed to be required to give, a
disclosure under the Financial Markets
Conduct Act 2013 in relation to the financial
products to which this disclosure relates:
Not applicable
Certification
I, Amanda Koo, certify that, to the best of my knowledge and belief, the information contained in
this disclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
---
Block Trade Agreement
relating to
Sale of Shares in Sanford Limited
Forsyth Barr Group Limited
Underwriter
and
Ngāi Tahu Investments Limited
Vendor
Date 3 June 2026
50747875
i
Contents
1.Definitions and Interpretation .................................................................................... 1
2.Sale of Sale Shares ..................................................................................................... 2
3.Settlement ................................................................................................................... 3
4.Fees and costs ............................................................................................................ 3
5.Representations and warranties ................................................................................ 3
6.Undertakings of the Vendor ....................................................................................... 7
7.Indemnity..................................................................................................................... 8
8.Termination ................................................................................................................. 9
9.Announcements ........................................................................................................ 11
10.Tax ............................................................................................................................. 11
11.Notice ........................................................................................................................ 12
12.General ...................................................................................................................... 12
50747875
1
This Block Trade Agreement is made on 3 June 2026
between (1) Forsyth Barr Group Limited (Underwriter)
and (2)Ngāi Tahu Investments Limited (Vendor)
Introduction
A. The Vendor owns 18,607,721 existing fully paid ordinary shares (Shares) in Sanford Limited
(the Company).
B. This Agreement sets out the terms and conditions upon which the Vendor engages the
Underwriter to arrange, manage and underwrite the sale of 8,969,621 Shares (Sale Shares)
held by the Vendor (Sale).
C. The Underwriter agrees to arrange, manage and underwrite the Sale in accordance with the
terms of this Agreement.
It is agreed
1.Definitions and Interpretation
1.1 In this Agreement, unless the context requires otherwise:
Affiliate has the meaning set forth in Rule 501(b) under the U.S. Securities Act and means,
in relation to a specified person, any related companies of the person and any person that
directly or indirectly through one or more intermediaries, controls or is controlled by, or is
under common control with, the person specified; and "control" (including the terms
"controlled by" and "under common control with") means the possession, direct or indirect, of
the power to direct or cause the direction of the management and policies of a person,
whether through the ownership of voting securities, by contract or otherwise;
Business Day means a day on which:
(a) NZX is open for trading in securities; and
(b) banks are open for general banking business in Auckland, New Zealand;
CCLA means the Contract and Commercial Law Act 2017;
FMA means the Financial Markets Authority established under the Financial Markets
Authority Act 2011;
FMCA means the Financial Markets Conduct Act 2013;
GST means goods and services tax chargeable under the GST Act;
GST Act means the Goods and Services Tax Act 1985;
NZX means NZX Limited or the main board equity securities market operated by it (as the
context requires);
50747875
2
NZX Listing Rules means the NZX Limited Listing Rules as amended from time to time;
Regulation S means Regulation S promulgated under the U.S. Securities Act;
Takeovers Code means the Takeovers Code made pursuant to the Takeovers Act 1993
and set out in the schedule to the Takeovers Regulations 2000;
Timetable means the timetable set out in Schedule 1; and
U.S. Securities Act means the U.S. Securities Act of 1933.
1.2 Interpretation: In this Agreement, unless expressly stated otherwise the following principles
of interpretation apply:
(a) headings and sub-headings are for convenience only and do not affect interpretation;
(b) a reference to legislation or to a provision of legislation includes a modification or re-
enactment of it, a legislative provision substituted for it and a regulation or statutory
instrument issued under it;
(c) a reference to "dollars" and "$" is to New Zealand currency;
(d) references to the singular include the plural and vice versa;
(e) references to a person include an individual, company, corporation, partnership, firm,
joint venture, association, trust, unincorporated body of persons, governmental or
other regulatory body, authority or entity, in each case whether or not having a
separate legal identity;
(f) references to any obligations not to do anything includes obligation not to suffer,
permit or cause that thing to be done;
(g) references to any document (however described) are references to that document as
novated, supplemented, altered or replaced from time to time and in any form,
whether on paper or in an electronic form;
(h) a reference to a right or obligation of any two or more persons confers that right, or
imposes that obligation, severally and not jointly and severally; and
(i) all references to time are to New Zealand time.
2. Sale of Sale Shares
2.1 Subject to the terms of this Agreement, the Vendor agrees to sell the Sale Shares in
accordance with the Timetable. The Timetable may be amended by the Vendor with the
prior written consent of the Underwriter. All references to dates in this Agreement have the
same meaning as in the Timetable and any defined terms not otherwise defined in this
Agreement but defined in the Timetable have the meaning given to them in the Timetable.
2.2 The Underwriter shall arrange and manage the Sale by inviting investors to bid through a
bookbuild process (Bookbuild) for the Sale Shares and using its best endeavours to procure
purchasers for the Sale Shares at or above a floor price per Share of $7.15 (Floor Price).
The final sale price will be determined by the Underwriter and the Vendor at the conclusion
of the Bookbuild (Sale Price) but in any event will not be less than the Floor Price. The
Underwriter will, in consultation with the Vendor, determine the allocation of the Sale Shares
to persons who have bid for the Sale Shares by no later than the Trade Date.
50747875
3
2.3 The Vendor and the Underwriter agree to conduct the Sale by way of offer only to persons in
New Zealand, or to persons outside New Zealand who are institutional or professional
investors in such jurisdictions to whom the Underwriter is reasonably satisfied that offers for
sale of securities may lawfully be made without requiring the preparation, delivery,
lodgement or filing of any prospectus or other disclosure document or any other lodgement,
registration of filing with, or approval by, a government agency (other than any such
requirement with which the Vendor, in its sole and absolute discretion, is willing to comply).
2.4 The Sale Shares shall only be offered and sold to persons that are (i) not in the United
States or (ii) dealers or other professional fiduciaries organised, incorporated or (if an
individual) resident in the United States that are acting for a discretionary or similar account
(other than an estate or trust) held for the benefit or account of persons that are not "U.S.
persons" (as defined in Regulation S) for which they have, and are exercising, investment
discretion, within the meaning of Rule 902(k)(2)(i) of Regulation S (Eligible U.S. Fund
Managers), in either case that acquire Sales Shares in "offshore transactions" (as defined in
Rule 902(h) under the U.S. Securities Act).
2.5 The Underwriter shall underwrite the Sale by purchasing or procuring the purchase of, at the
Sale Price per Sale Share, the number of Sale Shares which have not been purchased by
third party purchasers (or the Underwriter's Affiliates) as at 5.00pm on the Settlement Date.
3. Settlement
3.1 The Sale of the Sale Shares shall be effected through the Underwriter on 5 June 2026 (the
Trade Date) with settlement taking place on a "T+2" basis in accordance with New Zealand
Clearing Limited's Clearing and Settlement Rules (Settlement Date).
3.2 Subject to clause 8, on the Settlement Date:
(a) the Vendor shall take all steps reasonably necessary to procure settlement of the Sale
Shares; and
(b) the Underwriter shall arrange for the payment to the Vendor, or as the Vendor directs,
by 5.00pm on the Settlement Date of an amount equal to the Sale Price multiplied by
the number of Sale Shares without counterclaim, set-off or deduction (other than any
agreed fees payable under clause 4), by transfer to the account nominated by the
Vendor in writing for value (in cleared funds) against delivery of the Sale Shares.
4. Fees and costs
4.1 In consideration of performing its obligations under this Agreement, the Underwriter shall be
entitled to such fees and costs as the parties agree.
4.2 The fees payable under this clause 4 are payable and conditional on receipt by the Vendor
of the proceeds of sale of the Sale Shares to which the fees relate.
5. Representations and warranties
5.1 As at the date of this Agreement and on each day until and including the Settlement Date,
the Vendor represents and warrants to the Underwriter that:
(a) it is a body corporate validly existing and duly established under the laws of its place
of incorporation;
50747875
4
(b) it has taken, or will have taken by the time required, all corporate action, necessary to
authorise its entry into this Agreement and to carry out the transactions that this
Agreement contemplates;
(c) it has full legal capacity and power to enter into this Agreement and to carry out the
transactions that this Agreement contemplates;
(d) this Agreement constitutes its legal, valid and binding obligation, enforceable against it
in accordance with its terms;
(e) the Sale Shares may be offered in New Zealand under the Sale without disclosure to
investors under the FMCA;
(f) the Vendor does not control the Company within the meaning of clause 48 of
Schedule 1 of the FMCA;
(g) the sale of the Sale Shares and compliance by the Vendor with its obligations under
this Agreement will not conflict with, result in a breach or violation of, or constitute a
default under:
(i) any agreement or instrument to which the Vendor is a party or by which it or any
of its assets is bound; or
(ii) any statute, rule or regulation applicable to, or any order of any court or
governmental agency with jurisdiction over, the Vendor or its assets;
(h) it is the registered holder and sole legal owner of the Sale Shares and will transfer the
full legal and beneficial ownership of those Sale Shares free and clear of all liens,
charges, security interests, claims, equities and pre-emptive rights, subject to
registration of the transferee(s) in the register of shareholders of the Company;
(i) following sale, the Sale Shares will rank equally in all respects with all other
outstanding Shares, including their entitlement to dividends;
(j) the Sale Shares are quoted on the NZX;
(k) all information provided by the Vendor to the Underwriter in writing in relation to the
Sale is true and correct in all material respects and not misleading or deceptive,
whether by omission or otherwise in any material respect;
(l) the sale of the Sale Shares by the Vendor will not constitute a violation by it of Subpart
2 of Part 5 of the FMCA;
(m) it has not taken and will not take, directly or indirectly, any action designed to, or that
might reasonably be expected to, cause or result in the stabilisation or manipulation of
the price of the Sale Shares in violation of any applicable law;
(n) neither it, its Affiliates nor any person acting on behalf of any of them (other than the
Underwriter or its Affiliates or any person acting on behalf of any of them (if
applicable), as to whom it makes no representation) has engaged or will engage in
any "directed selling efforts" (as that term is defined in Rule 902(c) under the U.S.
Securities Act);
(o) the Company is a "foreign issuer" as defined in Rule 405 under the U.S. Securities Act
and it reasonably believes that there is no "substantial U.S. market interest" (as
defined in Rule 902(j) under the U.S. Securities Act) in the Sale Shares or any security
of the same class or series as the Sale Shares;
50747875
5
(p) the operations of the Vendor are conducted in all material respects in compliance with
all applicable anti-money laundering laws and regulations (collectively, the Money
Laundering Laws) and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Vendor with
respect to the Money Laundering Laws is pending or, to the best of the Vendor's
knowledge, threatened;
(q) neither the Vendor nor any director or, to the best of the Vendor's knowledge, any
agent, employee, Affiliate or other person acting on behalf of the Vendor has engaged
in any activity or conduct that would violate any applicable anti-bribery or anti-
corruption law or regulation or which would cause the Underwriter to be in breach of
any applicable anti-bribery or anti-corruption law or regulation; and the Vendor has
conducted its businesses in compliance with the applicable anti-bribery or anti-
corruption law or regulation and have instituted and maintained policies and
procedures designed to comply with such laws, rules and regulations;
(r) neither the Vendor nor any of its directors or, to the best of the Vendor's knowledge,
any of its agents, employees or Affiliates is an individual or entity (a Person) that is, or
is owned or controlled by Persons that are:
(i) the target of any sanctions administered or enforced by the Office of Foreign
Assets Control of the U.S. Department of the Treasury (OFAC), the U.S.
Department of State, the United Nations Security Council, the European Union,
the Commonwealth of Australia, His Majesty's Treasury or any other relevant
sanctions authority (collectively, the Sanctions); or
(ii) located, organised or resident in a country or territory that is, or whose
government is, the target of Sanctions, including, without limitation, the Crimea
region, Donetsk and Luhansk regions of Ukraine, Cuba, Iran, North Korea,
Sudan, Syria and Russia (a Sanctions Target), nor is the Vendor transacting
business, directly or indirectly, with a Sanctions Target.
5.2 As at the date of this Agreement and on each day until and including the Settlement Date,
the Underwriter represents and warrants to the Vendor that:
(a) it is a body corporate validly existing and duly established and duly incorporated under
the laws of its place of incorporation;
(b) it has taken, or will have taken by the time required, all corporate action necessary to
authorise its entry into this Agreement and to carry out the transactions that this
Agreement contemplates;
(c) it has full legal capacity and power to enter into this Agreement and to carry out the
transactions that this Agreement contemplates;
(d) this Agreement constitutes its legal, valid and binding obligation, enforceable against it
in accordance with its terms;
(e) it holds all licences, permits and authorities necessary for it to fulfil its obligations
under this Agreement;
(f) except with the prior approval of the Vendor, it has not communicated the possible
Sale to any potential investor or bookbuild participant prior to entry into this
Agreement;
(g) in connection with the Sale and/or subsequent sale of the Sale Shares, it (or its
Affiliates) will not enter into any contract or arrangement, or arrive at any
understanding, with any other person that contains an unlawful cartel provision for the
purposes of section 30 of the Commerce Act 1986 or any other analogous competition
50747875
6
law, or otherwise give effect to an unlawful cartel provision or any other contract,
arrangement or understanding that would breach applicable competition law. In
particular the Underwriter must make its own independent decisions whether to hold
or sell any Sale Shares, and if so, for how long and at what price;
(h) neither it nor any of its Affiliates has taken or will take, directly or indirectly, any action
designed to, or that might reasonably be expected to, cause or result in the
stabilisation or manipulation of the price of the Sale Shares in violation of any
applicable law;
(i) any resales by it (or any of its Affiliates) of Sale Shares will be arranged by it (or its
Affiliate) as principal and independently of the Vendor, and it will ensure that any
resales in any jurisdiction comply with all applicable laws and that the manner of any
resales is such that the Vendor will not be liable in respect of such resales under the
laws of any relevant jurisdiction, whether as a promoter or otherwise;
(j) it has made its own independent enquiry and investigations in relation to the Sale
Shares and the Company and has entered into this Agreement in reliance solely on its
own judgment and not in reliance on any representations or conduct of the Vendor or
any of its representatives (other than those expressly set out in this Agreement);
(k) it and its Affiliates will perform their obligations under this Agreement, including any
resale of the Sale Shares by the Underwriter or its Affiliates, in accordance with all
applicable laws and regulations in any relevant jurisdiction, including the FMCA, the
Takeovers Code and the Overseas Investment Act 2005, provided that it shall not be
in breach of this warranty to the extent any breach is caused by any act or omission of
the Vendor which constitutes a breach by the Vendor of its representations,
warranties, or undertakings in clause 5.1 or clause 6;
(l) it acknowledges that the offer and sale of the Sale Shares have not been and will not
be registered under the U.S. Securities Act and may not be offered or sold in the
United States except pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the U.S Securities Act;
(m) none of it, its Affiliates nor any person acting on behalf of any of them has engaged or
will engage in any "directed selling efforts" (as that term is defined in Rule 902(c)
under the U.S. Securities Act); and
(n) it, its Affiliates and any person acting on behalf of any of them has only offered and
sold the Sale Shares, and will only offer and sell the Sale Shares (1) to persons
outside the United States, and (2) to Eligible U.S. Fund Managers, in either case in
"offshore transactions" (as defined in Rule 902(h) under the U.S. Securities Act) in
accordance with Regulation S under the U.S. Securities Act.
5.3 Each party acknowledges that the other party has relied on the above representations and
warranties given by it and will continue to rely on these representations and warranties in
performing its obligations under this Agreement. The above representations and warranties
continue in full force and effect notwithstanding completion of this Agreement.
5.4 Each party agrees that it will notify the other party immediately upon becoming aware, prior
to settlement of the Sale Shares on the Settlement Date, of any of the following occurring:
(a) any material change affecting any of the foregoing representations and warranties; or
(b) any of the foregoing representations or warranties becoming materially untrue or
materially incorrect.
50747875
7
6. Undertakings of the Vendor
6.1 The Vendor will approach the Company promptly after the Agreement is signed and request
a trading halt in respect of trading in the Company’s ordinary shares on the NZX be put in
place in accordance with the Timetable.
6.2 The Vendor undertakes to the Underwriter that the Vendor is and will remain, at all times
prior to settlement on the Settlement Date, in compliance with the FMCA, the Takeovers
Code, any other applicable laws or regulations in New Zealand, the NZX Listing Rules, its
constitution and any legally binding requirement of the FMA and NZX insofar as applicable to
the Vendor, in each case to the extent such breach impacts or could reasonably be expected
to impact the sale of the Sale Shares, this Agreement or the Company.
6.3 The Vendor undertakes to the Underwriter that it will not, unless otherwise waived by the
Underwriter in writing, from the date of this Agreement until 5.00pm on the 90
th
calendar day
from the date of this Agreement (Escrow Period), Deal in all or any of the Vendor's Shares
held by it in the Company (Remaining Securities) after settlement of the Sale of the Sale
Share pursuant to this Agreement, excluding:
(a) transactions in order to satisfy demand from eligible shareholders under a Company
initiated dividend or distribution reinvestment plan;
(b) a repurchase (whether buy-back, reduction of capital or other means) of the
Remaining Securities by the Company;
(c) any acceptance by the Vendor of a takeover offer for the Company in accordance with
the Takeovers Code or transfer pursuant to a scheme of arrangement under Part 15 of
the Companies Act 1993 (including entry into any pre-bid agreement permitted by the
Takeovers Code in advance of a takeover offer);
(d) a sale, transfer or disposal to a third party where it is a condition of the sale that the
third party announce an intention to acquire, or propose a transaction to acquire,
greater than 50% of the ordinary shares of the Company;
(e) the grant of an encumbrance or transfer of any (or all) of its Remaining Securities (as
relevant) to a bona fide third party financial institution (Financial Institution) as
security for a loan, hedge or other financial accommodation provided that such
agreement with a Financial Institution must provide that the Remaining Securities are
to remain in escrow and subject to the terms of this Agreement as if the Financial
Institution were a party to this Agreement; or
(f) a sale, transfer or disposal to an Affiliate of the Vendor that is subject to an
undertaking on substantially the same terms as this clause 6.3 in respect of the
Remaining Securities sold, transferred or disposed. For the avoidance of doubt, any
agreement by the Affiliate will be in respect of the Escrow Period.
6.4 Each party acknowledges that:
(a) the undertaking in clause 6.3 is not intended to give the Underwriter any power to
dispose of, or control the disposal of, the Remaining Securities and to the extent that
the Underwriter would be in breach of applicable laws to have such power, a breach of
the undertaking in clause 6.3 under those circumstances will only give rise to a right to
damages and the parties acknowledge that, in such circumstances, damages are an
adequate remedy for a breach of the undertaking;
(b) the undertaking in clause 6.3 has been provided to only address the financial
consequence of the Vendor disposing of, or dealing with, any Remaining Securities
held by it; and
50747875
8
(c) the Underwriter is not entitled to a remedy of specific performance for a breach of the
undertaking in clause 6.3.
6.5 For the purposes of clause 6.3, "Deal" in respect of the Remaining Securities means:
(a) sell, assign, transfer or otherwise dispose of;
(b) agree to offer to sell, assign, transfer or otherwise dispose of;
(c) enter into any option which, if exercised (whether such exercise is subject to
conditions or otherwise), enables or requires the Vendor to sell, assign, transfer of
otherwise dispose of; or
(d) decrease or agree to decrease an economic interest in,
the Remaining Securities.
7. Indemnity
7.1 The Vendor agrees to indemnify and hold harmless, to the maximum extent permitted by
law, the Underwriter and its Affiliates and their respective directors, partners, officers, and
employees (Indemnified Persons) against any losses, damages, liabilities, costs,
expenses, claims, actions and demands (Losses) to the extent that such Losses are
incurred in connection with the Sale or this Agreement, including as a result of any breach of
this Agreement (including any breach of the above representations and warranties) by the
Vendor, and will reimburse an Indemnified Person for all reasonable and properly incurred
out of pocket costs, charges and expenses which it may properly pay or incur in connection
with investigating, disputing or defending in good faith and on reasonable grounds any such
claim, action or demand for which it is indemnified under this Agreement.
7.2 The indemnity in clause 7.1 does not extend to and is not to be taken as an indemnity
against any Losses of an Indemnified Person to the extent any Losses:
(a) have resulted solely from any resale in the ordinary course of any Sale Shares
acquired pursuant to this Agreement as underwriter or acquired as a result of
transactions undertaken on any Indemnified Person's own account;
(b) have resulted from any fraud, wilful misconduct or gross negligence of any
Indemnified Person or its Affiliates, or their respective directors, officers or employees;
(c) constitute a penalty or fine which the Indemnified Person is required to pay for any
contravention of any law by any Indemnified Person or its Affiliates, or their respective
directors, officers or employees;
(d) comprise an amount in respect of which the indemnity would be illegal, void or
unenforceable under any applicable law; or
(e) have resulted from any breach by the Underwriter of this Agreement, except to the
extent such a breach resulted from an act or omission on the part of the Vendor.
7.3 The Vendor also agrees that no claim shall be made by it against any Indemnified Person to
recover any Losses that the Vendor may suffer or incur by reason of or arising out of the
carrying out or the performance by any Indemnified Person of their obligations under this
Agreement. This release does not, however, apply to the extent that such Losses resulted
from any of the matters set out in clauses 7.2(a) to (e) applying to the Indemnified Person
claiming the benefit of this release.
50747875
9
7.4 The Vendor and the Underwriter must not (and the Underwriter shall procure that each
Indemnified Person must not) make any admission of liability or settle any action, demand or
claim to which the indemnity in clause 7.1 relates without the prior written consent of both the
Vendor and the Underwriter (such consent not to be unreasonably withheld or delayed).
7.5 An Indemnified Person must notify the Vendor upon becoming aware of any facts or
circumstances which may give rise to a claim or liability under this indemnity against the
Vendor pursuant to the indemnity under clause 7.1. The failure of an Indemnified Person to
notify the Vendor pursuant to this clause 7.5 will not release the Vendor from any obligation
or liability which it may have pursuant to this Agreement except that, if the Indemnified
Person's failure to notify results in a defence no longer being available to the Vendor or an
increase in the amount payable by the Vendor under the indemnity under clause 7.1, the
amount payable to the Indemnified Person under the indemnity in clause 7.1 will be reduced
by the extent to which the Vendor would suffer loss or damage as a consequence of that
failure on the part of the Indemnified Person to notify the Vendor.
7.6 The indemnity in clause 7.1 and the release in clause 7.3 are continuing obligations,
separate and independent from the other obligations of the parties under this Agreement and
survive termination or completion of this Agreement.
7.7 Without prejudice to any claim an Indemnified Person may have against the Vendor under
clause 7.1, no proceedings may be taken against any director, officer, employee or agent of
the Vendor in respect of any claim the Indemnified Person may have against the Vendor
under clause 7.1.
7.8 The parties agree that, for the purposes of Subpart 1 of Part 2 of the CCLA:
(a) the indemnity in clause 7.1 and the release in clause 7.3 is intended to confer a
benefit on, and be enforceable by, each Indemnified Person; and
(b) the provisions of this clause 7.7 are intended to confer a benefit on, and be
enforceable by, any such director, officer, employee or agent of the Vendor.
7.9 For the purposes of this clause 7, the term "Losses" or "Loss" does not include loss or
liability with respect to any damage to reputation or any consequential, special or indirect
damages, economic loss, loss of profits or opportunities suffered or incurred by any of the
Indemnified Persons, however caused.
8. Termination
8.1 If any of the following events occurs, then the Underwriter may terminate this Agreement in
its entirety without cost or liability to itself at any time commencing on the execution of this
Agreement and ending at the earlier of (i) 5.00pm on the Settlement Date and (ii) completion
of settlement of the Sale Shares on the Settlement Date (Risk Period) by giving written
notice to the Vendor:
(a) NZX does any of the following:
(i) announces that the Company will be removed from the official list of NZX or
ordinary shares in the Company will be suspended from quotation (other than
with the approval (not to be unreasonably withheld or delayed), or at the
request, of the Underwriter);
(ii) removes the Company from the official list of the NZX; or
(iii) suspends the trading of ordinary shares in the Company on the NZX for any
period of time (unless as contemplated by clause 6.1 or otherwise only as a
consequence or in contemplation of the Sale);
50747875
10
(b) FMA issues or threatens to issue proceedings in relation to the Sale or commences, or
threatens to commence any inquiry or investigation in relation to the Sale (other than
in respect of the actions of the Underwriter or any of its Affiliates where such actions
are not contemplated by this Agreement); or
(c) subject to clause 8.2, any of the following occurs:
(i) a general moratorium on commercial banking activities in New Zealand,
Australia, United States or the United Kingdom is declared by the relevant
central banking authority in any of those countries, or there is a material
disruption in commercial banking or security settlement or clearance services in
any of those countries;
(ii) the Vendor is in default of any of the terms and conditions of this Agreement or
breaches any representation or warranty given or made by it under this
Agreement; or
(iii) there is introduced, or there is a public announcement of a proposal to
introduce, into the Parliament of New Zealand a new law, or the Government of
New Zealand, the Reserve Bank of New Zealand or any Minister or other
governmental authority of New Zealand adopts or announces a proposal to
adopt a new policy (other than a law or policy which has been announced
before the date of this Agreement).
8.2 No event listed in clause 8.1(c) entitles the Underwriter to exercise its termination rights
unless, in the reasonable opinion of the Underwriter, it:
(a) has, or would reasonably be expected to have, a material adverse effect on:
(i) the willingness of persons to purchase the Sale Shares at the Floor Price; or
(ii) the price at which ordinary shares in the Company are sold on the NZX; or
(b) will or would reasonably be expected to give rise to a contravention by the Underwriter
of the FMCA or any other applicable law.
8.3 If, at any time during the Risk Period, the Underwriter or any of its Affiliates is in default of
any provision of this Agreement or breaches any representation, warranty or undertaking
given or made by it under this Agreement, then the Vendor may at any time before the expiry
of the Risk Period, by giving written notice to the Underwriter, immediately terminate this
Agreement in its entirety without cost or liability to itself.
8.4 The Vendor is not entitled to exercise its termination rights under clause 8.3 unless, in the
reasonable opinion of the Vendor, the relevant breach or default by the Underwriter or any of
its Affiliates:
(a) has, or would be reasonably expected to have, a material adverse effect on the
willingness of persons to purchase the Sale Shares at the Floor Price; or
(b) would reasonably be expected to give rise to a material liability of the Vendor or any of
its Affiliates under the FMCA or any other applicable law.
8.5 If this Agreement is terminated in accordance with this clause 8:
(a) neither the Underwriter nor the Vendor will have any obligations under this Agreement
(including, in the case of the Vendor, the obligation to pay any fees to the
Underwriter); and
50747875
11
(b) such termination will be without prejudice to any accrued rights or obligations arising
before or in relation to such termination (including, in the case of any Indemnified
Person, any right to be indemnified) which shall survive.
9. Announcements
9.1 The Vendor and the Underwriter will consult each other in respect of any material public
releases by any of them concerning the Sale. The prior written consent of the Vendor must
be obtained prior to the Underwriter making any public release or public announcement or
engaging in publicity in relation to the Sale and such release, announcement or engagement
must be in compliance with all applicable laws, including the securities laws of New Zealand,
Australia, the United States and any other jurisdiction.
10. Tax
10.1 Unless the context otherwise requires, all words and phrases used in this clause 10 that are
defined in the GST Act have the meanings given in the GST Act. Reference to a person is
deemed to include a reference to the representative member of any GST group of which that
person is a member.
10.2 The parties record their understanding that any supplies made in New Zealand by the
Underwriter in discharging its obligations to the Vendor under this Agreement that are
subject to the GST Act are supplies of financial services that are (subject to clause 10.3)
exempt supplies under and for the purposes of the GST Act.
10.3 The Vendor acknowledges that the Underwriter may seek to treat supplies that are subject to
the GST Act and are made by the Underwriter under this Agreement as zero-rated for GST
purposes under section 11A(1)(q) or (r) the GST Act. For this purpose, the Vendor confirms
that it will provide reasonable assistance to the Underwriter in connection with determining
whether, or to what extent, supplies under this Agreement may be zero-rated under those
provisions, but will give no warranty, representation or other assurance whatsoever with
respect to this matter.
10.4 If any supply made under this Agreement is a taxable supply, the recipient of the supply
(Recipient) must pay to the party making the taxable supply (Supplier), in addition to and at
the same time as the consideration otherwise payable for that supply, but subject to the
Recipient's receipt of the requisite taxable supply information issued by the Supplier in
respect of that supply, an amount equal to the GST charged in respect of that supply (GST
Amount).
10.5 If the GST payable by the Supplier in connection with a taxable supply made under or in
connection with this Agreement differs from the GST Amount paid by the Recipient under
this clause 10, the Supplier must repay any excess to the Recipient or the Recipient must
pay any deficiency to the Supplier, as appropriate within five business days of the Supplier
providing the Recipient with a written notification regarding the difference in the GST
payable. Where the difference in the GST payable results from an event referred to in
section 25(1) of the GST Act, supply correction information will be issued as required by the
GST Act.
10.6 If any amounts payable by either party to the other party under this Agreement are
calculated by reference to a cost or expense incurred by the other party, the amount payable
to the other party under any other provision of this Agreement must be reduced by the
amount of any input tax credit or deduction from output tax to which the other party is entitled
in connection with that cost or expense.
10.7 If any amount payable by either party to the other under this Agreement is or becomes
subject to any withholding tax or other deduction required by law, the amount payable by the
paying party to the other under this Agreement will be reduced by the relevant withholding
50747875
12
tax or deduction and the paying party will not be required to gross up or otherwise
compensate the other party on account of the withholding tax or deduction.
11. Notice
11.1 Each notice or other communication given under this Agreement is to be in writing, is to be
made by personal delivery, or email to the addressee at the address, and is to be marked for
the attention of the person or office holder (if any), from time to time designated for the
purpose by the addressee to the other party. The initial address, email address and relevant
person or office holder of each party is set out below:
Vendor: Ngāi Tahu Investments Limited
Attention: Todd Moyle
Email: todd.moyle@ngaitahu.iwi.nz
Address: 15 Show Place
Addington
Christchurch 8024
New Zealand
Underwriter: Forsyth Barr Group Limited
Attention: Kerry Greer
Email: Kerry.greer@forsythbarr.co.nz
Address: Level 23, 88 Shortland St, Auckland 1010
11.2 No communication is to be effective until received. A communication will, however, be
deemed to be received by the addressee:
(a) in the case of personal delivery, when delivered; and
(b) in the case of email, on the date and time at which it enters the addressee's email
information system (as shown in the delivery report from the sender's information
system).
12. General
12.1 This Agreement, account opening and client documentation completed by the Vendor and
any separate agreement relating to fees, together constitute the entire agreement of the
parties about its subject matter and supersedes all previous agreements, understandings
and negotiations on that matter.
12.2 This Agreement is governed by the laws of New Zealand. Each party submits to the non-
exclusive jurisdiction of courts exercising jurisdiction in New Zealand.
12.3 This Agreement may not be amended, waived or varied without the written agreement of
both parties (it being specifically acknowledged that the consent of any third party expressly
stated to be entitled to rely on this Agreement will not be required to such an amendment,
waiver or variation).
12.4 No party may assign its rights or obligations under this Agreement without the prior written
consent of the other party.
50747875
13
12.5 Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction will
be ineffective as to that jurisdiction to the extent of the prohibition or unenforceability. That
will not invalidate the remaining provisions of this Agreement nor affect the validity or
enforceability of that provision in any other jurisdiction.
12.6 Time is of the essence in each party's performance of its obligations under this Agreement.
12.7 A provision of or right vested under this Agreement may not be:
(a) waived except in writing signed by the party granting the waiver; or
(b) varied except in writing signed by the parties.
12.8 The rights and obligations of the parties will not merge on the completion of the Sale.
Following termination of this Agreement, any provision intended to remain in force will
continue to do so in accordance with its terms.
12.9 Each party agrees, at its own expense, on the request of the other party, to do everything
reasonably necessary to give effect to this Agreement and the transactions contemplated by
it, including, but not limited to, the execution of documents.
12.10 A party may give conditionally or unconditionally or withhold its approval or consent in its
absolute discretion unless this Agreement expressly provides otherwise.
12.11 This Agreement may be executed in any number of counterparts. All counterparts, together,
will be taken to constitute one agreement.
12.12 The Vendor agrees that the Underwriter may provide the services under this Agreement
through appropriately licensed Affiliates to the extent necessary to permit the Underwriter to
comply with applicable laws in the various jurisdictions in which it undertakes activities in
relation to this Agreement. In such case, each of the relevant Underwriter's Affiliates will
have the benefit of the Vendor's obligations under this Agreement and will be able to enforce
those obligations pursuant to Subpart 1 of Part 2 of the CCLA.
12.13 The Vendor acknowledges that:
(a) the Underwriter is not obliged to disclose to the Vendor or utilise for the benefit of the
Vendor, any non-public information which the Underwriter obtains in the normal
course of its business where such disclosure or use would result in a breach of any
obligation of confidentiality or any internal information barrier policies of the
Underwriter;
(b) without prejudice to any claim the Vendor may have against the Underwriter or any of
its Affiliates, no proceedings may be taken against any director, officer, employee or
agent of the Underwriter or its Affiliates in respect of any claim that the Vendor may
have against the Underwriter or its Affiliates;
(c) it is contracting with the Underwriter on an arm's length basis to provide the services
described in this Agreement and the Underwriter has not assumed, and is not
assuming, any duties or obligations (fiduciary or otherwise) in respect of the Vendor
other than those expressly set out in this Agreement; and
(d) the Underwriter is a full service securities and corporate advisory firm and commercial
bank and, along with its Affiliates, the Underwriter is engaged in various activities,
including writing research, securities trading, investment management, corporate
advisory, financing and brokerage activities and financial planning and benefits
counselling for both companies and individuals. In the ordinary course of these
activities, the Underwriter, its Affiliates, employees and officers may be providing, or
may be in the future providing, financial or other services to other parties with
50747875
14
conflicting interests to the Vendor and may receive fees for those services and may
actively trade the debt and equity securities (or related derivative securities), loans or
other financial products of those persons for the Underwriter's account and for the
account of its customers and may at any time hold long and short positions in such
financial products.
50747875
15
Execution
Executed as a block trade agreement.
Signed for and on behalf of Ngāi
Tahu Investments Limited by
Authorised signatory
Print Name
Signed for and on behalf of Forsyth
Barr Group Limited by
Authorised Signatory Authorised Signatory
Print Name Print Name
Todd Moyle
50747875
16
Schedule 1: Timetable
Event Time (NZT)
Trading halt commences
Approximately 9.00am, 4 June 2026
Book opens Approximately 10.00am, 4 June 2026
Book closes Approximately 5.00pm, 4 June 2026
Trading halt lifted Approximately 9.00am, 5 June 2026
Trade Date 5 June 2026
Settlement Date (T+2) 9 June 2026
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- SPG — Stride Property Limited: SPH Notice - Forsyth Barr Investment Management Limited2026-05-11
“1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Section 277 and 278, Financial Markets Conduct Act 2013 To: NZX Limited and To: Stride Property Ltd & Stride Investment Management Ltd (NS) Relevant event b…”
- PCT — Precinct Properties New Zealand Limited: SPH Notice - Forsyth Barr Investment Management Limited2026-05-06
“1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Section 277 and 278, Financial Markets Conduct Act 2013 To: NZX Limited and To: Precinct Properties NZ & Precinct Properties Investments Ltd Relevant event…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: SPH Notice - Pinnacle Investment Management Group Limited2026-05-18
“1 Disclosure of beginning to have substantial holding Section 276, Financial Markets Conduct Act 2013 To NZX and ASX and To Fisher & Paykel Healthcare Corp. Ltd Date this disclosure made:18/05/2026 Date on which substantial holding began:13/05/2026 Substantial product hol…”